# Farmabios

markets a portfolio of corticosteroid APIs, with a long-standing position in adrenal-cortical and reproductive-hormone manufacturing.

Source: https://en.bioecon.ru/companies/farmabios/
Updated: 2026-07-20

- Country: Italy

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Total of over €80 million invested in Farmabios as of 2025 (including a €35 million expansion announced in 2025 and €45 million previously committed over five years) | https://www.axplora.com/news/axplora-announces-further-40m-expansion-at-farmabios-to-double-footprint-and-fuel-long-term-growth/, https://www.bioprocessintl.com/facilities-capacity/axplora-to-fund-41m-expansion-of-farmabios-facility-to-bolster-eu-footprint, https://www.outsourcedpharma.com/doc/axplora-announces-further-m-expansion-at-farmabios-fuel-long-term-growth-0001 |
| Certification | cGMP approved by AIFA; holds multiple GMP certificates for active pharmaceutical ingredients (APIs) | https://chemanager-online.com/en/news/axploras-farmabios-gets-cgmp-approval-for-new-production-unit-in-italy, https://extranet.who.int/prequal/sites/default/files/whopir_files/WHOPIR_DeskAssess_Farmabios02-05Nov2020.pdf, https://manufacturingchemist.com/farmabios-achieves-cgmp-approval-for-large-scale-hpapi, https://www.axplora.com/news/farmabios-an-axplora-company-granted-cgmp-approval-from-aifa-for-extended-production-capacity-in-hpapis-and-steroids/, https://www.manufacturingchemist.com/farmabios-achieves-cgmp-approval-for-large-scale-hpapi, https://www.outsourcedpharma.com/doc/farmabios-an-axplora-company-granted-cgmp-approval-from-aifa-for-extended-production-capacity-in-hpapis-and-steroids-0001 |
| Regulatory approval | cGMP approval from AIFA for large-scale HPAPI and steroid production; site inspected and considered compliant with WHO GMP guidelines | https://chemanager-online.com/en/news/axploras-farmabios-gets-cgmp-approval-for-new-production-unit-in-italy, https://extranet.who.int/prequal/sites/default/files/whopir_files/WHOPIR_DeskAssess_Farmabios02-05Nov2020.pdf, https://manufacturingchemist.com/farmabios-achieves-cgmp-approval-for-large-scale-hpapi, https://www.axplora.com/news/farmabios-an-axplora-company-granted-cgmp-approval-from-aifa-for-extended-production-capacity-in-hpapis-and-steroids/, https://www.manufacturingchemist.com/farmabios-achieves-cgmp-approval-for-large-scale-hpapi, https://www.outsourcedpharma.com/doc/farmabios-an-axplora-company-granted-cgmp-approval-from-aifa-for-extended-production-capacity-in-hpapis-and-steroids-0001 |
| Production site | Gropello Cairoli, Italy (Via Pavia, 1) | https://extranet.who.int/prequal/sites/default/files/whopir_files/WHOPIR_DeskAssess_Farmabios02-05Nov2020.pdf, https://www.fatturatoazienda.it/azienda/farmabios-spa-00180280182 |
| Headcount | 375 employees as of 2024 | https://www.axplora.com/news/axplora-announces-further-40m-expansion-at-farmabios-to-double-footprint-and-fuel-long-term-growth/, https://www.bioprocessintl.com/facilities-capacity/axplora-to-fund-41m-expansion-of-farmabios-facility-to-bolster-eu-footprint, https://www.fatturatoazienda.it/azienda/farmabios-spa-00180280182, https://www.outsourcedpharma.com/doc/axplora-announces-further-m-expansion-at-farmabios-fuel-long-term-growth-0001 |
| Revenue | 127.4 million EUR for fiscal year 2024 | https://www.fatturatoazienda.it/azienda/farmabios-spa-00180280182 |

Independent sources: axplora.com, bioprocessintl.com, chemanager-online.com, extranet.who.int, fatturatoazienda.it, manufacturingchemist.com, outsourcedpharma.com

## Technologies

- [Biosynthetic steroids (fermentation & biocatalytic API)](https://en.bioecon.ru/technology/biosynthetic-steroids/)